High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia : a phase II study by the Japan Adult Leukemia Study Group

• YANADA M

収録刊行物

• J Clin Oncol.

  J Clin Oncol. 24 460-466, 2006

詳細情報

• CRID: 1574231875337272832
• NII論文ID: 10021932720
• データソース種別:
  • CiNii Articles